Raptor Pharmaceuticals Expands Board of Directors and Scientific Advisory Board

17-Jul-2008

Raptor Pharmaceuticals Corp. announced the appointments of Richard L. Franklin, M.D., Ph.D. to the Company's board of directors and Stephen C. Blacklow, M.D., Ph.D. to its scientific advisory board.

Dr. Franklin has 25 years of experience in the biomedical industry. He is currently Chairman of Synthemed, Inc., a publicly traded medical device company; and DMS Data Systems, an Internet-based information services company. He is also Executive Chairman of Tarix, a subsidiary of medical products company, Phairson, Ltd, where he sits on the board of directors. During his career, Dr. Franklin has founded a healthcare consulting firm, Richard Franklin & Associates, and led the Healthcare Corporate Finance Team at Tucker Anthony, an investment bank. He received a bachelor's degree from Harvard University, an M.A. in mathematics from the University of Washington, a Ph.D. in mathematics from Brandeis University, and an M.D. from Boston University School of Medicine.

Dr. Blacklow contributes scientific exerptise from academia to Raptor's scientific advisory board. He is an Associate Professor of Pathology and a Director of the M.D. Ph.D. program, basic sciences track, at Harvard Medical School. He also directs a research laboratory at the Brigham and Women's Hospital, a teaching affiliate of Harvard Medical School. Recently, Dr. Blacklow's team determined the structure of the RAP d3 protein complexed with receptor. Over the last ten years, Dr. Blacklow's research team has achieved international recognition for mechanistic and structural studies of low-density lipoprotein or LDL receptor proteins, and for work on the structure and function of human Notch proteins. Dr. Blacklow received his M.D. and Ph.D. in bioorganic chemistry from Harvard University in 1991.

Other news from the department people

Most read news

More news from our other portals

So close that even
molecules turn red...